GIACOMELLI, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 12.029
NA - Nord America 3.338
EU - Europa 1.656
SA - Sud America 1.308
AF - Africa 125
OC - Oceania 46
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.504
Nazione #
SG - Singapore 6.959
US - Stati Uniti d'America 3.152
HK - Hong Kong 2.069
CN - Cina 1.906
BR - Brasile 1.029
GB - Regno Unito 607
VN - Vietnam 578
IT - Italia 286
DE - Germania 214
IN - India 138
CA - Canada 115
AR - Argentina 113
NL - Olanda 98
ID - Indonesia 86
JP - Giappone 62
UA - Ucraina 61
EC - Ecuador 59
ZA - Sudafrica 59
MX - Messico 55
BD - Bangladesh 52
TR - Turchia 52
FR - Francia 47
AU - Australia 41
PL - Polonia 40
ES - Italia 38
FI - Finlandia 36
CO - Colombia 33
RU - Federazione Russa 32
PY - Paraguay 28
AT - Austria 27
CZ - Repubblica Ceca 25
SE - Svezia 25
CL - Cile 19
PE - Perù 18
PT - Portogallo 18
MA - Marocco 15
PK - Pakistan 14
EG - Egitto 13
KZ - Kazakistan 12
IL - Israele 11
IQ - Iraq 10
DK - Danimarca 9
LT - Lituania 9
RO - Romania 9
BG - Bulgaria 8
SA - Arabia Saudita 8
TN - Tunisia 8
CH - Svizzera 7
GR - Grecia 7
IR - Iran 7
TH - Thailandia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EE - Estonia 5
IE - Irlanda 5
JO - Giordania 5
LB - Libano 5
LU - Lussemburgo 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
BE - Belgio 4
GH - Ghana 4
KE - Kenya 4
KW - Kuwait 4
OM - Oman 4
RS - Serbia 4
SN - Senegal 4
AF - Afghanistan, Repubblica islamica di 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IS - Islanda 3
KR - Corea 3
PH - Filippine 3
QA - Qatar 3
SI - Slovenia 3
YT - Mayotte 3
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
GT - Guatemala 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TL - Timor Orientale 2
TW - Taiwan 2
ZM - Zambia 2
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 18.480
Città #
Hong Kong 2.046
Singapore 1.346
Hefei 1.101
Ashburn 840
Boardman 616
London 525
Shanghai 350
Dallas 331
Ho Chi Minh City 218
Beijing 206
Council Bluffs 187
Los Angeles 118
Hanoi 113
Pune 94
San Francisco 92
São Paulo 92
Amsterdam 72
Munich 61
Toronto 61
Rome 57
Washington 51
Seattle 48
Tokyo 45
Santa Clara 44
New York 42
Warsaw 33
Brooklyn 30
Haiphong 28
Ankara 25
Montreal 23
Rio de Janeiro 23
Turku 23
Chicago 22
Da Nang 22
Johannesburg 22
Biên Hòa 20
Brasília 20
Stockholm 20
West Jordan 20
Brno 19
Quito 19
Thái Bình 19
Boston 18
Curitiba 18
Bari 17
Guangzhou 17
Guayaquil 17
Chennai 15
Jinan 15
Manchester 15
Mexico City 15
Campinas 14
Hải Dương 14
Phoenix 14
Porto Alegre 14
Atlanta 13
Belo Horizonte 13
Guarulhos 13
Melbourne 13
Sydney 13
Vienna 13
Buenos Aires 12
Helsinki 12
Lima 12
Can Tho 11
Charlotte 11
Naples 11
Paris 11
Qingdao 11
Barcelos 10
Frankfurt am Main 10
Manaus 10
Milan 10
Secaucus 10
Cape Town 9
Hanover 9
Jakarta 9
Nuremberg 9
The Dalles 9
Asunción 8
Bogotá 8
Canberra 8
Changsha 8
Fortaleza 8
Goiânia 8
Hangzhou 8
Hortolândia 8
Jaguariúna 8
Joinville 8
Lấp Vò 8
Ninh Bình 8
Salvador 8
Santo André 8
Cairo 7
Formosa 7
Maceió 7
Madrid 7
Natal 7
Oklahoma City 7
Osasco 7
Totale 9.772
Nome #
------- 214
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 208
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 207
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 202
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 198
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 191
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 183
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 182
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 180
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 173
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 166
A comprehensive review on adult onset Still's disease 165
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 165
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 165
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 161
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 158
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 155
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 153
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 150
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 148
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 146
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 127
Adult-onset Still's disease with elderly onset: results from a multicentre study 120
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 120
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 117
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 100
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 96
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 96
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 95
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 94
Cytokine storm syndrome in severe COVID-19 90
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 89
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 88
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 85
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 85
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 83
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 81
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 81
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 79
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 79
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 78
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 77
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 77
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 74
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 74
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 72
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 70
Cardiovascular disease in primary sjögren’s syndrome 68
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 68
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 64
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 62
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 59
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 54
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 54
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 53
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 53
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 50
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 50
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 48
The Vessels Contribute to Fibrosis in Systemic Sclerosis 48
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 48
The economic burden of fibromyalgia: A systematic literature review 46
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 46
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 46
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 46
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 44
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 43
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 43
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 43
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 42
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 41
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 41
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 41
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 41
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 41
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects 41
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 40
Interferenza farmacologica "in vitro" sulla aderenza batterica agli spermatozoi 40
il sistema immunitario 40
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 40
Development and implementation of the AIDA International Registry for patients with Behçet's disease 39
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 39
Shulman, malattia di 39
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 39
Emergenze cliniche in corso di allergia al veleno di imenotteri. 38
Effects of cadmium (Cd) and zinc (Zn) ions on lymphocyte cultures. 38
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 38
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 38
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 37
Rituximab in primary Sjögren's syndrome: a ten-year journey 37
Gamma/delta T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosis 37
Ultrastructural alterations of refrigerated vs cryopreserved human semen 37
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 36
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders 36
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 36
Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome 36
IL-6 production from peripheral blood mononuclear cells (PBMC) of patients affected by progressive systemic sclerosis (PSS). 36
Morphological study on the interaction between enterococci and human spermatozoa 36
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 36
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 36
Totale 8.325
Categoria #
all - tutte 201.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/20265.035 1.556 496 1.216 1.767 0 0 0 0 0 0 0 0
Totale 18.654